What's in the Cards for CME Group This Earnings Season?

Zacks
Ouvrir sur Zacks
What's in the Cards for CME Group This Earnings Season?

CME Group Inc. CME is expected to register a decline in both top and bottom lines when it reports second-quarter 2026 results on July 22, before the opening bell.

The Zacks Consensus Estimate for CME’s second-quarter revenues is pegged at $1.69 billion, indicating a 0.1% decrease from the year-ago reported figure.

The consensus estimate for earnings is pegged at $2.93 per share. The Zacks Consensus Estimate for CME’s second-quarter earnings has moved 2.3% south in the past 30 days. The estimate suggests a year-over-year decrease of 1%.

What the Zacks Model Says

Our proven model does not conclusively predict an earnings beat for CME Group this time around. This is because the stock has the right combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), which increases the chances of an earnings beat. This is not the case, as you can see below.

Earnings ESP: CME Group has an Earnings ESP of -1.04%. This is because the Most Accurate Estimate of $2.90 is pegged lower than the Zacks Consensus Estimate of $2.93. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.

CME Group Inc. Price and EPS Surprise

CME Group Inc. Price and EPS Surprise

CME Group Inc. price-eps-surprise | CME Group Inc. Quote

Zacks Rank: CME Group currently carries a Zacks Rank of 4 (Sell). 

Factors Likely to Shape Q2 Results

CME Group’s second-quarter results are likely to benefit from its diversified product portfolio, heightened market volatility and strong competitive position.

Revenue growth is likely to have been aided by gains in market data and information services, as well as higher clearing, transaction and other fee-based income.

Increased volatility across asset classes appears to have boosted trading volumes, which, in turn, supported clearing and transaction fees. The Zacks Consensus Estimate for clearing and transaction fees stands at $1.4 billion, indicating a 1.7% decrease compared with the same period last year.

CME Group reported a quarterly average daily volume (ADV) of 29.8 million contracts in the second quarter, which declined 1% year over year. Trading activity decreases across multiple segments, including interest rates, energy and foreign exchange. Agricultural ADV of 2.1 million contracts in the second quarter of 2026 increased 6% from the prior-year period. Equity Index ADV of 8.6 million contracts increased 13% year over year.

Market data and information services revenues are likely to have benefited from pricing adjustments on certain products as well as increased demand and usage. The Zacks Consensus Estimate for this segment is pegged at $227 million, suggesting a 14.6% year-over-year increase.

On the cost side, expenses are expected to have risen during the quarter, primarily due to higher spending on employee compensation and benefits, along with increased investment in technology.

Stocks to Consider

Here are three finance stocks you may want to consider, as our model shows that these also have the right combination of elements to post an earnings beat.

Cboe Global Markets, Inc. CBOE has an Earnings ESP of +1.82% and carries a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $3.41, indicating a year-over-year increase of 38.6%. You can see the complete list of today’s Zacks #1 Rank stocks here.

CBOE’s earnings beat estimates in each of the last four reported quarters.

Cincinnati Financial Corporation CINF has an Earnings ESP of +8.84% and a Zacks Rank #2 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $1.77, indicating a year-over-year decrease of 10.1%.

CINF’s earnings beat estimates in each of the last four reported quarters.

The Allstate Corporation ALL has an Earnings ESP of +23.32% and a Zacks Rank #3 at present. The Zacks Consensus Estimate for second-quarter 2026 earnings is pegged at $4.92, indicating a year-over-year decrease of 17.1%.

ALL’s earnings beat estimates in each of the last four reported quarters.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."

Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention. 

See them now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
CME Group Inc. (CME): Free Stock Analysis Report
 
Cincinnati Financial Corporation (CINF): Free Stock Analysis Report
 
The Allstate Corporation (ALL): Free Stock Analysis Report
 
Cboe Global Markets, Inc. (CBOE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research